Airsculpt Technologies, Inc. ( (AIRS) ) has released its Q2 earnings. Here is a breakdown of the information Airsculpt Technologies, Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AirSculpt Technologies, Inc. is a national provider of premium body contouring procedures, specializing in minimally invasive treatments that optimize comfort and precision for its clients. The company operates within the healthcare sector, focusing on innovative body sculpting solutions.
In its latest earnings report for the second quarter of fiscal 2025, AirSculpt Technologies announced a strategic advancement in its transformation initiatives, despite a year-over-year decline in revenue. The company highlighted a record growth in leads and consultations, reflecting a strong consumer interest in its services. Additionally, the company announced the upcoming retirement of its Chief Financial Officer, Dennis Dean, who will remain in his role until a successor is appointed.
The financial performance for the second quarter of 2025 showed a revenue decline of 13.7% to $44 million, with a net loss of $0.6 million, an improvement from the previous year’s net loss of $3.2 million. The case volume also saw a decline of 14.1%, while adjusted EBITDA decreased to $5.8 million from $6.9 million in the same quarter of the previous year. The company also reported a reduction in its debt by $16 million, following a successful common stock offering in June.
For the first six months of 2025, AirSculpt reported a revenue decline of 15.5% to $83.4 million, with a net loss of $3.4 million compared to a net income of $2.8 million in the first half of 2024. The company maintained its full-year revenue and adjusted EBITDA guidance, projecting revenues between $160 to $170 million and adjusted EBITDA of $16 to $18 million.
Looking ahead, AirSculpt Technologies remains confident in its growth strategy, focusing on new offerings such as skin tightening and expanded financing options to enhance consumer flexibility. The company believes that these initiatives, along with its strengthened balance sheet, position it well for future growth and improved sales performance.